|
US2443266A
(en)
*
|
1944-09-02 |
1948-06-15 |
Bendix Aviat Corp |
Commutator brush holder
|
|
US3117142A
(en)
|
1961-03-01 |
1964-01-07 |
Roussel Uclaf |
Novel preparation of estradiol and estrone
|
|
US3169134A
(en)
|
1963-03-21 |
1965-02-09 |
Searle & Co |
2, 3-oxygenated-17alpha-methyl-5alpha-androstan-17beta-ols
|
|
BE754111A
(fr)
|
1969-07-29 |
1971-01-29 |
Upjohn Co |
Nouveaux 7alpha- et 7beta-methyl-3alpha,5alpha- cycloandrostanes et composes analogues 19-nor et leur procede de preparation
|
|
US3943124A
(en)
|
1970-12-17 |
1976-03-09 |
Gordon Hanley Phillipps |
Chemical compounds
|
|
US3983111A
(en)
|
1972-05-05 |
1976-09-28 |
Glaxo Laboratories Limited |
Steroidal anaesthetics of the pregnane and 19-norpregnane series
|
|
GB1430942A
(en)
|
1972-05-05 |
1976-04-07 |
Glaxo Lab Ltd |
21-substituted 3alpha-hydroxy pregnanes
|
|
US3865939A
(en)
|
1973-02-23 |
1975-02-11 |
Procter & Gamble |
Edible oils having hypocholesterolemic properties
|
|
US4071625A
(en)
|
1974-05-13 |
1978-01-31 |
Richardson-Merrell Inc. |
19-Oxygenated-5α-androstanes for the enhancement of libido
|
|
US4192871A
(en)
|
1976-01-06 |
1980-03-11 |
Glaxo Laboratories Limited |
Chemical compounds
|
|
GB1570394A
(en)
|
1976-01-06 |
1980-07-02 |
Glaxo Lab Ltd |
11-acyloxy-3-hydroxy steroids
|
|
GB1581234A
(en)
|
1976-04-05 |
1980-12-10 |
Glaxo Operations Ltd |
11a - amino - 3a - hydroxysteroids
|
|
US5847009A
(en)
|
1986-01-14 |
1998-12-08 |
Alliance Pharmaceutical Corp. |
Prophylaxis in the parenteral administration of particulate dispersions in fluorocarbon emulsions
|
|
SE8600632D0
(sv)
|
1986-02-13 |
1986-02-13 |
Kabivitrum Ab |
Novel pharmaceutical composition
|
|
US5120723A
(en)
|
1987-08-25 |
1992-06-09 |
University Of Southern California |
Method, compositions, and compounds for modulating brain excitability
|
|
US5319115A
(en)
|
1987-08-25 |
1994-06-07 |
Cocensys Inc. |
Method for making 3α-hydroxy, 3β-substituted-pregnanes
|
|
US5232917A
(en)
|
1987-08-25 |
1993-08-03 |
University Of Southern California |
Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
|
|
US5719197A
(en)
|
1988-03-04 |
1998-02-17 |
Noven Pharmaceuticals, Inc. |
Compositions and methods for topical administration of pharmaceutically active agents
|
|
US4938763B1
(en)
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
|
KR0166088B1
(ko)
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
MY107937A
(en)
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
|
JPH06510999A
(ja)
|
1991-09-13 |
1994-12-08 |
コセンシス・インコーポレイテッド |
ステロイド結合部位を有する新規ＧＡＢＡ↓ａレセプター
|
|
US5411737A
(en)
|
1991-10-15 |
1995-05-02 |
Merck & Co., Inc. |
Slow release syneresing polymeric drug delivery device
|
|
AU698834B2
(en)
|
1993-05-24 |
1998-11-12 |
Purdue Pharma Ltd. |
Methods and compositions for inducing sleep
|
|
EP0656365B1
(en)
|
1993-12-02 |
1997-04-09 |
Akzo Nobel N.V. |
Substituted 2beta-morpholinoandrostane derivatives
|
|
US5939545A
(en)
|
1994-02-14 |
1999-08-17 |
Cocensys, Inc. |
Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
|
|
DK0752860T3
(da)
|
1994-02-14 |
2000-11-13 |
Euro Celtique Sa |
Androstaner og pregnaner til allosterisk modulering af GABA-receptor
|
|
CN1087725C
(zh)
|
1994-03-25 |
2002-07-17 |
同位素技术有限公司 |
用氘代方法增强药物效果
|
|
AU3125695A
(en)
|
1994-07-21 |
1996-02-22 |
Pharmacia & Upjohn Company |
Neurologically active aminosteroids
|
|
AP653A
(en)
|
1994-11-23 |
1998-07-21 |
Cocensys Inc |
Androstane and pregnane series for allosteric modulations of gaba receptor.
|
|
EP1288220A3
(en)
|
1995-06-06 |
2004-07-21 |
Euro-Celtique |
Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series
|
|
US6780853B1
(en)
|
1995-06-06 |
2004-08-24 |
Euro-Celtique S.A. |
Neuroactive steroids of the androstane and pregnane series
|
|
EP0840612A1
(en)
|
1995-07-24 |
1998-05-13 |
Trustees Of Boston University |
Inhibition of nmda receptor activity by pregnenolone sulfate derivatives
|
|
WO1998005337A1
(en)
|
1996-08-01 |
1998-02-12 |
Cocensys, Inc. |
Use of gaba and nmda receptor ligands for the treatment of migraine headache
|
|
ES2221019T3
(es)
|
1996-10-31 |
2004-12-16 |
Takeda Chemical Industries, Ltd. |
Preparacion de liberacion mantenida.
|
|
US7630757B2
(en)
|
1997-01-06 |
2009-12-08 |
Flint Hills Scientific Llc |
System for the prediction, rapid detection, warning, prevention, or control of changes in activity states in the brain of a subject
|
|
US6046177A
(en)
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
US5874418A
(en)
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
US6316613B1
(en)
|
1997-07-25 |
2001-11-13 |
Beckman Coulter, Inc. |
Chiral separation of pharmaceutical compounds with charged cyclodextrins using capillary electrophoresis
|
|
US6245757B1
(en)
|
1997-10-03 |
2001-06-12 |
Research Corporation Technologies, Inc. |
Use of progestins to treat ischemic event
|
|
CN1270718C
(zh)
*
|
1998-03-11 |
2006-08-23 |
托布乔恩·贝克斯托罗姆 |
表别孕烷醇酮在制备治疗甾族化合物诱导的疾病的药物中的应用
|
|
US20020198174A1
(en)
|
2001-05-07 |
2002-12-26 |
Allergan Sales, Inc. |
Disinfecting and solubilizing steroid compositions
|
|
US6376531B1
(en)
|
1998-11-13 |
2002-04-23 |
Rupert Charles Bell |
Method of treatment using deuterium compounds
|
|
US20030236236A1
(en)
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
|
DK1104760T3
(da)
|
1999-12-03 |
2003-06-30 |
Pfizer Prod Inc |
Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
|
|
US6442887B2
(en)
|
2000-02-25 |
2002-09-03 |
Robert L. Sanquist |
Live bait keeper
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
US20020072509A1
(en)
*
|
2000-10-11 |
2002-06-13 |
Stein Donald Gerald |
Methods for the treatment of a traumatic central nervous system injury
|
|
EP1216713A1
(en)
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Compositions of estrogen-cyclodextrin complexes
|
|
GR1003861B
(el)
|
2000-12-29 |
2002-04-11 |
|
Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
|
|
CA2443266A1
(en)
|
2001-02-13 |
2002-08-22 |
University Of Florida |
A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
WO2002094244A2
(en)
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of benzodiazepines through an inhalation route
|
|
US7090830B2
(en)
|
2001-05-24 |
2006-08-15 |
Alexza Pharmaceuticals, Inc. |
Drug condensation aerosols and kits
|
|
WO2002094218A2
(en)
|
2001-05-24 |
2002-11-28 |
Alexza Molecular Delivery Corporation |
Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
|
|
JP2003063965A
(ja)
*
|
2001-06-13 |
2003-03-05 |
Otsuka Pharmaceut Factory Inc |
注射用シロスタゾール水性製剤
|
|
WO2003076476A2
(en)
|
2002-01-14 |
2003-09-18 |
Ansell Healthcare Products, Inc. |
Magnetically detectable latex articles
|
|
US7550155B2
(en)
|
2002-07-29 |
2009-06-23 |
Transform Pharmaceuticals Inc. |
Aqueous pharmaceutical compositions of 2,6-diisopropylphenol (propofol) and their uses
|
|
JP2006506445A
(ja)
|
2002-08-28 |
2006-02-23 |
ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド |
治療処置の方法
|
|
US9339508B2
(en)
|
2003-01-17 |
2016-05-17 |
Mapreg |
Use of 3-methoxy-pregnenolone for the preparation of a drug for treating a traumatic brain injury
|
|
CA2527019A1
(en)
|
2003-05-29 |
2005-01-06 |
Washington University |
Neuroactive 13,24-cyclo-18,21-dinorcholanes and structurally-related pentacyclic steroids
|
|
WO2005011612A2
(en)
|
2003-07-31 |
2005-02-10 |
The Research Foundation Of State University Of New York |
Alpha 4 beta 2 delta gaba-a receptors as a strategy for pms and alcoholism
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
JP2007515425A
(ja)
*
|
2003-12-22 |
2007-06-14 |
シェーリング コーポレイション |
医薬組成物
|
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
|
ATE497787T1
(de)
|
2004-03-12 |
2011-02-15 |
Cipla Ltd |
Sterilisationsprozess für steroide
|
|
US20090118248A1
(en)
|
2004-04-23 |
2009-05-07 |
Euro-Celtique S.A. |
3-Alpha-hydroxy 21-n-heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof
|
|
ITMI20041763A1
(it)
|
2004-09-16 |
2004-12-16 |
Altergon Sa |
Nuove formulazioni iniettabili contenenti progesterone
|
|
WO2006034196A1
(en)
|
2004-09-17 |
2006-03-30 |
Lifelike Biomatic Inc. |
Compositions for enhancing memory and methods therefor
|
|
US8604011B2
(en)
|
2004-09-27 |
2013-12-10 |
The Regents Of The University Of California |
Therapy for treatment of chronic degenerative brain diseases and nervous system injury
|
|
US8557861B2
(en)
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
|
CA2582231A1
(en)
|
2004-09-29 |
2006-10-19 |
Hollis-Eden Pharmaceuticals, Inc. |
Steroid analogs and uses
|
|
CN101180071A
(zh)
|
2004-12-07 |
2008-05-14 |
普罗特奥里克斯公司 |
抑制蛋白酶体的组合物
|
|
EP1853234A2
(en)
|
2005-02-15 |
2007-11-14 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
|
EP2030622B1
(en)
|
2005-03-24 |
2011-02-23 |
Emory University |
Indication of dosage of progesterone in the treatment of a traumatic brain injury
|
|
AU2006235318A1
(en)
|
2005-04-07 |
2006-10-19 |
Hythiam, Inc. |
Improved methods of and compositions for the prevention of anxiety, substance abuse, and dependence
|
|
US20110319386A1
(en)
|
2005-08-26 |
2011-12-29 |
Braincells Inc. |
Neurogenesis by muscarinic receptor modulation
|
|
KR100784860B1
(ko)
|
2005-10-31 |
2007-12-14 |
삼성전자주식회사 |
비휘발성 메모리 장치 및 그 제조 방법
|
|
ES2812250T3
(es)
|
2005-11-28 |
2021-03-16 |
Marinus Pharmaceuticals Inc |
Formulaciones de ganaxolona y procedimientos para la preparación y uso de las mismas
|
|
TWI376239B
(en)
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
|
US20070287931A1
(en)
|
2006-02-14 |
2007-12-13 |
Dilorenzo Daniel J |
Methods and systems for administering an appropriate pharmacological treatment to a patient for managing epilepsy and other neurological disorders
|
|
EP2068872A1
(en)
|
2006-09-08 |
2009-06-17 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
|
US20090239942A1
(en)
|
2006-09-15 |
2009-09-24 |
Cloyd James C |
Topiramate Compositions and Methods of Making and Using the Same
|
|
US20090203658A1
(en)
|
2007-01-08 |
2009-08-13 |
Duke University |
Neuroactive steroid compositions and methods of use therefor
|
|
US20090074677A1
(en)
|
2007-01-08 |
2009-03-19 |
Duke University |
Neuroactive steroid compositions and methods of use therefor
|
|
US7813811B2
(en)
|
2007-02-08 |
2010-10-12 |
Neuropace, Inc. |
Refillable reservoir lead systems
|
|
SI3461503T1
(sl)
|
2007-04-11 |
2022-04-29 |
Biomarin Pharmaceutical Inc. |
Postopki za dajanje tetrahidrobiopterina, povezani sestavki in postopki merjenja
|
|
US8530463B2
(en)
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
|
EP2167098B1
(en)
*
|
2007-06-11 |
2018-09-05 |
University Of Southern California |
Allopregnanolone in a method for enhancing neurological function (alzheimer disease)
|
|
CA2698172C
(en)
|
2007-06-15 |
2014-02-18 |
Cook, Kevin M. |
Androstane and pregnane steroids with potent allosteric gaba receptor chloride ionophore modulating properties
|
|
GB0711948D0
(en)
|
2007-06-20 |
2007-08-01 |
Bionature E A Ltd |
Neurosteriod compounds
|
|
US20100316678A1
(en)
|
2007-06-28 |
2010-12-16 |
Cnsbio Pty Ltd. |
Combination methods and compositions for treatment of neuropathic pain
|
|
JP2011507800A
(ja)
|
2007-12-26 |
2011-03-10 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
癲癇、精神障害、または感覚器官の障害のためのａｍｐａ受容体アンタゴニスト
|
|
WO2009088530A1
(en)
|
2008-01-03 |
2009-07-16 |
Biomarin Pharmaceutical Inc. |
Pterin analog for treating bh4 responsive condition
|
|
US20090198145A1
(en)
|
2008-02-06 |
2009-08-06 |
Chow Harrison |
Compositions, methods, and systems for rapid induction and maintenance of continuous rem sleep
|
|
US8729070B2
(en)
|
2008-02-20 |
2014-05-20 |
Targia Pharmaceuticals |
CNS pharmaceutical compositions and methods of use
|
|
DE102008015366A1
(de)
|
2008-03-20 |
2009-09-24 |
Merck Patent Gmbh |
Lyophilisierte Nanoemulsion
|
|
CZ2008434A3
(cs)
|
2008-07-10 |
2009-12-09 |
Ústav organické chemie a biochemie Akademie ved CR, v. v. i. |
Pregnanové anionické slouceniny, zpusob jejich výroby a jejich použití
|
|
SMT202000257T1
(it)
|
2008-10-10 |
2020-07-08 |
Vm Discovery Inc |
Composizioni e metodi per il trattamento dei disturbi da uso di alcol, dolore e altre malattie
|
|
EP2376073A2
(en)
|
2008-11-30 |
2011-10-19 |
Oron Zachar |
Dermal application of vasoconstrictors
|
|
WO2010088409A2
(en)
*
|
2009-01-30 |
2010-08-05 |
Emory University |
Methods of neuroprotection using neuroprotective steroids and a vitamin d
|
|
WO2010107922A1
(en)
|
2009-03-17 |
2010-09-23 |
Duke University |
Neuroactive steroid compositions and methods of use for lowering cholesterol
|
|
WO2011079047A1
(en)
|
2009-12-23 |
2011-06-30 |
Drugtech Corporation |
Methods for reducing the occurrence of preterm delivery and other pregnancy-related conditions
|
|
US8697678B2
(en)
*
|
2010-01-21 |
2014-04-15 |
Drawbridge Pharmaceuticals Pty Ltd |
Anaesthetic formulation
|
|
RU2576506C2
(ru)
|
2010-11-03 |
2016-03-10 |
Санофи-Авентис Дойчланд Гмбх |
Игольчатая канюля, содержащая лекарственный препарат
|
|
WO2012075286A2
(en)
|
2010-12-01 |
2012-06-07 |
The Regents Of The University Of California |
Intrapulmonary benzodiazepine for the treatment and prevention of seizures
|
|
CZ201181A3
(cs)
|
2011-02-15 |
2012-09-12 |
Ústav organické chemie a biochemie Akademie ved CR, v.v.i. |
Deriváty pregnanolonu substituované v poloze 3alfa kationickou skupinou, zpusob jejich výroby, jejich použití a prostredek je obsahující
|
|
WO2012116290A2
(en)
|
2011-02-25 |
2012-08-30 |
Washington University |
Neuroactive 17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
|
|
FR2973031B1
(fr)
|
2011-03-23 |
2013-11-29 |
Univ Strasbourg |
Derives de l'allopregnanolone et de l'epiallopregnanolone et leurs utilisations pour traiter un etat neuropathologique
|
|
US9084797B2
(en)
|
2011-05-23 |
2015-07-21 |
Besins Healthcare Luxembourg Sarl |
Progesterone treatment for improving sleep quality
|
|
JP5893135B2
(ja)
|
2011-06-28 |
2016-03-23 |
ビボゾーン インコーポレイテッド |
多重ターゲッティングの相乗効果を誘発する有効物質の組合せ及びその用途
|
|
CA2843436A1
(en)
|
2011-07-29 |
2013-02-07 |
The Regents Of The University Of California |
Novel 17.beta.-heteroaryl-substituted steroids as modulators of gaba a receptors
|
|
FI2753632T3
(fi)
|
2011-09-08 |
2023-08-02 |
Sage Therapeutics Inc |
Neuroaktiivisia steroideja, koostumuksia ja niiden käyttöjä
|
|
US10478505B2
(en)
|
2011-09-23 |
2019-11-19 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
|
CA3152410A1
(en)
|
2011-10-14 |
2013-04-18 |
Sage Therapeutics, Inc. |
3,3-disubstituted 19-nor pregnane compounds, compositions, and uses thereof for the treatment of cns related disorders
|
|
BR112014012985B1
(pt)
|
2011-11-29 |
2020-05-12 |
Jurox Pty Ltd |
Composição farmacêutica injetável, seu método de produção e uso, bem como método de conservação de uma composição farmacêutica injetável e uso de pelo menos um co-solvente e pelo menos um conservante
|
|
RU2014121785A
(ru)
|
2011-11-29 |
2016-01-27 |
Амино Ап Кемикал Ко., Лтд. |
Композиция, содержащая виценин-2, обладающая благоприятным воздействием на неврологическую или когнитивную функцию
|
|
SMT202000008T1
(it)
|
2012-01-23 |
2020-03-13 |
Sage Therapeutics Inc |
Formulazione di steroide neuroattivo comprendente un complesso di allopregnanolone e solfobutil eter beta-ciclodestrina
|
|
US20150175651A1
(en)
|
2012-06-15 |
2015-06-25 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
WO2014028398A2
(en)
|
2012-08-13 |
2014-02-20 |
The Regents Of The University Of California |
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
|
|
PL2887944T3
(pl)
|
2012-08-21 |
2022-02-21 |
Sage Therapeutics, Inc. |
Allopregnanolon do leczenia lekoopornego stanu padaczkowego
|
|
WO2014058736A1
(en)
|
2012-10-08 |
2014-04-17 |
Washington University |
Neuroactive 19-alkoxy-17(20)-z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same
|
|
US9757391B2
(en)
|
2012-11-09 |
2017-09-12 |
Goodchild Investments Pty Ltd |
Neuroactive steroids and their use to facilitate neuroprotection
|
|
ES2973320T3
(es)
|
2012-11-30 |
2024-06-19 |
Univ California |
Alopregnanolona para tratar, reducir o mitigar los síntomas de la depresión posparto
|
|
TR201808616T4
(tr)
|
2012-12-18 |
2018-07-23 |
Sage Therapeutics Inc |
Nöroaktif 19-alkoksi-17-ikameli steroidler, bunların ön ilaçları ve bunları kullanan tedavi yöntemleri.
|
|
WO2014108808A2
(en)
|
2013-01-09 |
2014-07-17 |
Henry James Lorne |
Pharmaceutical formulations for the treatment and prevention of trauma-induced neuropathology and neurodegeneration
|
|
US20160068563A1
(en)
|
2013-04-17 |
2016-03-10 |
Boyd L. Harrison |
19-nor neuroactive steroids and methods of use thereof
|
|
RU2019126333A
(ru)
|
2013-04-17 |
2019-10-08 |
Сейдж Терапьютикс, Инк. |
19-нор нейроактивные стероиды и способы их применения
|
|
CN113527400B
(zh)
|
2013-04-17 |
2024-06-28 |
萨奇治疗股份有限公司 |
19-去甲c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
|
|
WO2015195962A1
(en)
|
2014-06-18 |
2015-12-23 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
CA3254865A1
(en)
|
2015-02-06 |
2025-05-28 |
Marinus Pharmaceuticals, Inc. |
Intravenous ganaxolone formulations and their use in treating status epilepticus and other seizure disorders
|
|
GB2541015A
(en)
|
2015-08-06 |
2017-02-08 |
Ge Oil & Gas Uk Ltd |
Subsea flying lead
|
|
WO2017066240A1
(en)
|
2015-10-14 |
2017-04-20 |
The Regents Of The University Of California |
Enhancing beta cell replication and/or survival
|
|
RU2766155C2
(ru)
|
2016-03-08 |
2022-02-08 |
Сейдж Терапьютикс, Инк. |
Нейроактивные стероиды, их композиции и применения
|
|
US20180050005A1
(en)
|
2016-08-16 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Concentrated Solution of 17-Hydroxydocosahexaenoic Acid
|
|
US20180050107A1
(en)
|
2016-08-16 |
2018-02-22 |
Janssen Pharmaceutica Nv |
Neurosteroid compositions and methods of use thereof
|
|
IL265225B
(en)
|
2016-09-07 |
2022-08-01 |
Glia Llc |
Treatment of symptoms related to neurodegenerative disorders through pharmacological dermal activation of cranial nerves
|
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
|
WO2018169798A1
(en)
|
2017-03-11 |
2018-09-20 |
The Regents Of The University Of California |
Mitigation of cns disorders by combination therapy using neurosteroids, and ampa blockers
|
|
US20180296487A1
(en)
|
2017-04-18 |
2018-10-18 |
Marinus Pharmaceuticals, Inc. |
Sustained release injectable neurosteroid formulations
|
|
US11752115B2
(en)
|
2017-06-21 |
2023-09-12 |
The Board Of Trustees Of The University Of Illinois |
PPAR-alpha agonist treatment of neuropsychiatric disorders
|
|
JP7557185B2
(ja)
|
2017-06-23 |
2024-09-27 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
免疫応答を調節するｇａｂａの能力の強化
|
|
US11266663B2
(en)
|
2017-06-23 |
2022-03-08 |
The Board Of Trustees Of The University Of Illinois |
Treatment of neuropsychiatric disorders with neurosteroids and analogues thereof
|
|
WO2019051477A1
(en)
|
2017-09-11 |
2019-03-14 |
Sage Therapeutics, Inc. |
METHODS OF TREATING EPILEPSY OR EPILEPTIC MALE CONDITION
|
|
EP3681510A1
(en)
|
2017-09-14 |
2020-07-22 |
Sage Therapeutics, Inc. |
A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof
|
|
US20190160078A1
(en)
|
2017-11-10 |
2019-05-30 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in treating genetic epileptic disorders
|
|
KR20200096596A
(ko)
|
2017-12-08 |
2020-08-12 |
세이지 테라퓨틱스, 인크. |
Cns 장애의 치료를 위한 중수소화 21 -[4-시아노-피라졸-1 -일]-19-노르-프레간-3. 알파-올-20-온 유도체
|
|
IL275562B2
(en)
|
2017-12-22 |
2024-07-01 |
Sage Therapeutics Inc |
Compositions and methods for treating cns disorders
|
|
US20220315621A1
(en)
|
2017-12-22 |
2022-10-06 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
MA51568A
(fr)
|
2018-01-12 |
2021-04-21 |
Sage Therapeutics Inc |
Composés aza-, oxa et thia-pregnan-20-one-3.alpha.-ol s'utilisant dans le traitement de troubles du système nerveux central
|
|
JP2021523938A
(ja)
|
2018-05-04 |
2021-09-09 |
アセラス ファーマシュウティカルズ コーポレーション |
神経ステロイド誘導体およびその使用
|
|
CN117959309A
(zh)
|
2018-06-12 |
2024-05-03 |
萨奇治疗股份有限公司 |
19-去甲基c3,3-二取代的c21-n-吡唑基类固醇及其使用方法
|
|
DK3864022T3
(da)
|
2018-10-12 |
2023-12-18 |
Sage Therapeutics Inc |
Neuroaktive steroider substitueret i Position 10 med en cyklisk gruppe til anvendelse til behandlingen af CNS-lidelser
|
|
JP7534291B2
(ja)
|
2018-10-19 |
2024-08-14 |
セージ セラピューティクス， インコーポレイテッド |
９（１１）－不飽和神経刺激性ステロイド及びそれらの使用方法
|
|
IL312610B2
(en)
|
2018-12-05 |
2026-05-01 |
Sage Therapeutics Llc |
Neuroactive steroids and methods of using them
|
|
WO2020132504A1
(en)
|
2018-12-21 |
2020-06-25 |
Sage Therapeutics, Inc. |
3.alpha.-hydroxy-17.beta.-amide neuroactive steroids and compositions thereof
|
|
TWI855081B
(zh)
|
2019-05-24 |
2024-09-11 |
美商賽吉醫療公司 |
化合物、組合物及使用方法
|
|
CN114206900A
(zh)
|
2019-05-31 |
2022-03-18 |
萨奇治疗股份有限公司 |
神经活性类固醇及其组合物
|
|
AU2020395246A1
(en)
|
2019-12-05 |
2022-06-16 |
Sage Therapeutics, Inc. |
A 19-nor C3,3-disubstituted C21-N-pyrazolyl steroid and methods of use thereof
|
|
IL296371A
(en)
|
2020-03-18 |
2022-11-01 |
Sage Therapeutics Inc |
Neuroactive steroids and methods of using them
|
|
PE20221911A1
(es)
|
2020-03-25 |
2022-12-23 |
Sage Therapeutics Inc |
Uso de agentes para el tratamiento de condiciones respiratorias
|
|
BR112023000990A2
(pt)
|
2020-07-20 |
2023-03-28 |
Sage Therapeutics Inc |
Formulações de esteroide c21-n-pirazolil 19-nor c3,3- dissubstituído e métodos de uso das mesmas
|